Janssen Pharmaceutica NV

Where the EU money came from

Funding by EU programme. Amounts are Janssen Pharmaceutica NV's own share of each project, not the project's full budget.

Projects

145 EU-funded projects, newest first. Janssen Pharmaceutica NV led 6 of them as coordinator. Each links to the official record.

• IDEASPartner

  Improving Drug Efficacy with next-generation AmorphouS materials and trained experts

  Horizon Europe · 2026–2030 · Project on CORDIS ↗

  €289ktheir share
• PFAROSPartner

  Driving Sustainable Innovation to Minimise PFAS in European Healthcare

  Horizon Europe · 2026–2031 · Project on CORDIS ↗
• ABSOLUTEAssociated partner

  Towards predictive computational platform for drug solubilization in the gastrointestinal tract

  Horizon Europe · 2026–2029 · Project on CORDIS ↗
• FORTIFYPartner

  FORTIFY - FRAMEWORK FOR OPTIMIZED REGULATION, TRADE SECRETS, AND INTELLECTUAL PROPERTY IN A FEDERATED EUROPEAN HEALTH DATA SPACE

  Horizon Europe · 2026–2029 · Project on CORDIS ↗
• MedTechLabelPartner

  MedTechLabel: UNIFIED DIGITAL LABELLING FOR MEDICAL TECHNOLOGY PRODUCTS

  Horizon Europe · 2026–2029 · Project on CORDIS ↗
• MetaExplorePartner

  Ultrahigh-throughput exploration of metagenomic sequence space to discover and engineer novel biocatalysts and bioactive compounds

  Horizon Europe · 2026–2030 · Project on CORDIS ↗

  €289ktheir share
• BRIDGEPartner

  Breakthrough Regulatory Innovation and Development throuGh sandbox Environments

  Horizon Europe · 2025–2028 · Project on CORDIS ↗
• BIOPHAMAssociated partner

  Bio and Pharmaceutical Materials Science

  Erasmus+ (ERASMUS+) · 2025–2031 · Project on the EU portal ↗
• RealiseDPartner

  Comprehensive methodological and operational approach to clinical trials in rare and ultra-rare diseases

  Horizon Europe · 2025–2029 · Project on CORDIS ↗
• READIAssociated partner

  REpresentative Clinical Research - ADvancing Inclusivity in Europe

  Horizon Europe · 2025–2030 · Project on CORDIS ↗
• PROCRYSTALPartner

  Crystallisation towards efficient and sustainable biomanufacturing

  Horizon Europe · 2025–2028 · Project on CORDIS ↗

  €263ktheir share
• Project-COMFORTPartner

  Patient-Centric blOod saMpling FOr impRoved healThcare (Project-COMFORT)

  Horizon Europe · 2024–2028 · Project on CORDIS ↗
• PharmEcoPartner

  Advancing Safe and Sustainable by design Practices in Pharmaceutical Manufacturing

  Horizon Europe · 2024–2030 · Project on CORDIS ↗
• AutoPiXPartner

  IMAGING FOR PATIENT BENEFIT IN ARTHRITIS

  Horizon Europe · 2024–2029 · Project on CORDIS ↗
• VICT3RPartner

  Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research

  Horizon Europe · 2024–2028 · Project on CORDIS ↗
• SYNTHIAPartner

  Synthetic Data Generation Framework for Integrated Validation of Use Cases and AI Healthcare Applications

  Horizon Europe · 2024–2029 · Project on CORDIS ↗
• MobiliTraINAssociated partner

  Ion Mobility Mass Spectrometry Training Network

  Horizon Europe · 2024–2028 · Project on CORDIS ↗
• PANVIPREPPartner

  Developing broad-spectrum antiviral drugs for pandemic preparedness

  Horizon Europe · 2024–2027 · Project on CORDIS ↗

  €80ktheir share
• NextBasePartner

  Base metal-catalytic cross-coupling methodologies towards sustainability

  Horizon Europe · 2023–2027 · Project on CORDIS ↗

  €263ktheir share
• CTCANPartner

  Clinical Trials Community Africa Network

  Horizon Europe · 2023–2025 · Project on CORDIS ↗
• IMAGIOPartner

  IMAGING AND ADVANCED GUIDANCE FOR WORKFLOW OPTIMIZATION IN INTERVENTIONAL ONCOLOGY

  Horizon Europe · 2023–2028 · Project on CORDIS ↗
• IDERHAPartner

  Integration of heterogeneous Data and Evidence towards Regulatory and HTA Acceptance

  Horizon Europe · 2023–2028 · Project on CORDIS ↗
• MiELPartner

  Doctoral network for microprocess engineering for electrosynthesis - new synthesis concepts for pharmaceutical/ fine chemical industry

  Horizon Europe · 2023–2027 · Project on CORDIS ↗

  €263ktheir share
• GENEGUTPartner

  Oral delivery of encapsulated RNA nanotherapeutics for targeted treatment of ileal Crohn's disease

  Horizon Europe · 2022–2026 · Project on CORDIS ↗

  €299ktheir share
• DICECoordinator

  DIgital health in Circular Economy

  Horizon Europe · 2022–2026 · Project on CORDIS ↗

  €1.3Mtheir share
• RM ROADMAPAssociated partner

  CREATING FRAMEWORK CONDITIONS FOR RESEARCH MANAGEMENT TO STRENGTHEN THE EUROPEAN RESEARCH AREA

  Horizon Europe · 2022–2025 · Project on CORDIS ↗
• ECOTRONPartner

  How to minimize the ecological footprint for functional electronics?

  Horizon Europe · 2022–2026 · Project on CORDIS ↗

  €217ktheir share
• PROMISEPartner

  Preparing for RSV Immunisation and Surveillance in Europe

  Horizon 2020 · 2021–2024 · Project on CORDIS ↗
• EPNDPartner

  European platform for neurodegenerative disorders

  Horizon 2020 · 2021–2026 · Project on CORDIS ↗
• BEAMERPartner

  BEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe

  Horizon 2020 · 2021–2027 · Project on CORDIS ↗
• ALLODDPartner

  Allostery in Drug Discovery

  Horizon 2020 · 2021–2025 · Project on CORDIS ↗

  €256ktheir share
• UNITE4TBPartner

  ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS

  Horizon 2020 · 2021–2028 · Project on CORDIS ↗
• REALMENTPartner

  Using real-world big data from eHealth, biobanks and national registries, integrated with clinical trial data to improve outcome of severe mental disorders

  Horizon 2020 · 2021–2025 · Project on CORDIS ↗

  €502ktheir share
• BIGPICTUREPartner

  Central Repository for Digital Pathology

  Horizon 2020 · 2021–2027 · Project on CORDIS ↗
• T2EVOLVEPartner

  Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy

  Horizon 2020 · 2021–2025 · Project on CORDIS ↗
• InPharmaPartner

  A fully integrated, animal-free, end-to-end modelling approach to oral drug product development

  Horizon 2020 · 2021–2024 · Project on CORDIS ↗

  €384ktheir share
• DRUGtrainPartner

  Drug repurposing and discovery multidisciplinary training network

  Horizon 2020 · 2021–2024 · Project on CORDIS ↗

  €256ktheir share
• AIDDPartner

  Advanced machine learning for Innovative Drug Discovery

  Horizon 2020 · 2021–2025 · Project on CORDIS ↗

  €641ktheir share
• COLOTANPartner

  Boosting advanced doctoral training in innovative colon targeting drugs

  Horizon 2020 · 2021–2024 · Project on CORDIS ↗

  €256ktheir share
• Gravitate-HealthPartner

  Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment

  Horizon 2020 · 2020–2026 · Project on CORDIS ↗

Showing the 80 most recent of 145 projects.

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Novartis Pharma AGSwitzerland · 54 shared projects
• Astrazeneca ABSweden · 51 shared projects
• Pfizer LimitedUnited Kingdom · 51 shared projects
• F. Hoffmann-La Roche AGSwitzerland · 49 shared projects
• Sanofi-Aventis Recherche & DeveloppementFrance · 44 shared projects
• Eli Lilly and Company LtdUnited Kingdom · 41 shared projects
• Glaxosmithkline Research & Development LimitedUnited Kingdom · 40 shared projects
• Bayer AktiengesellschaftGermany · 39 shared projects
• The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 33 shared projects
• Ucb BiopharmaBelgium · 32 shared projects
• Boehringer Ingelheim InternationalgmbhGermany · 32 shared projects
• Merck Kommanditgesellschaft Auf AktienGermany · 30 shared projects
• Novo Nordisk A/SDenmark · 29 shared projects
• Katholieke Universiteit LeuvenBelgium · 25 shared projects
• Institut National de la Sante et de la Recherche MedicaleFrance · 25 shared projects
• Fraunhofer Gesellschaft zur Forderung der Angewandten Forschung eVGermany · 23 shared projects

Fields it works in

Research fields recorded on its Horizon projects.

• DNA
• RNA
• RNA viruses
• additive manufacturing
• adverse drug reactions
• alzheimer
• amorphous solids
• amyotrophic lateral sclerosis
• antibiotic resistance
• antibiotics
• antivirals
• aromatic compounds
• artificial intelligence
• asthma